Stake Purchase • Healthcare Services

Medirom Invests In Japan Gene Medicine

On June 30, 2024, Medirom invested in healthcare services company Japan Gene Medicine

Investment Context

This is Medirom’s 1st transaction in the Healthcare Services sector.
This is Medirom’s 3rd transaction in Japan.

Explore All 257 Stake Purchase Healthcare Services Deals - Search the Database Free

Investment Summary
Date	June 30, 2024
Target	Japan Gene Medicine
Sector	Healthcare Services
Investor(s)	Medirom
Deal Type	Stake Purchase

Target Company

Japan Gene Medicine

Tokyo, Japan

Japan Gene Medicine is a company engaged in the prenatal diagnosis business, providing genetic testing and analysis, and the company does business with major private, public, and university hospitals. Japan Gene Medicine was founded in 2019 and is based in Tokyo, Japan.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Investor Overview 1

Investor

Medirom

Tokyo, Japan

Category	Company
Founded	2000
Sector	Business Services
Employees	334
Revenue	8.3B USD (2024)

DESCRIPTION

Medirom is a healthcare general trading company that can provide comprehensive services from prevention to treatment, which provides the best combination of healthcare methods, products, and services to fit the user's lifestyle. Medirom was founded in 2000 and is based in Tokyo, Japan.

Deal Context for Investor	#
Overall	3 of 3
Sector: Healthcare Services	1 of 1
Type: Stake Purchase	1 of 1
Country: Japan	3 of 3
Year: 2024	1 of 1

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2021-04-30	SAWAN Japan SAWAN is a relaxation salon operator.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2021-04-30

SAWAN

Japan

SAWAN is a relaxation salon operator.

Buy

Explore Related M&A Activity

Healthcare Services M&A - Stake Purchase M&A Deals - Japan M&A - 2024 M&A